# A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

> **NCT00001104** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 538 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00001104
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1990-02
- **Target enrollment:** 538 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001104, "A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00001104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*